Influence of felbamate on selected central effects of ethanol in experimental animals

Acta Poloniae Pharmaceutica - Drug Research

Volumn 61, Issue 3, 2004, Pages 209-213

  Pietrzak, Bogusława ^a,b   Czarnecka, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Department of Pharmacodynamics ^*  (Poland)

Author keywords

Ethanol; Experimental animals; Felbamate; Interaction

Indexed keywords

ALCOHOL; FELBAMATE; ANTICONVULSIVE AGENT; CENTRAL DEPRESSANT AGENT; PROPANEDIOL DERIVATIVE;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ALCOHOL INTERACTION; ENZYME SUBSTRATE; HYPOTHERMIA; LOCOMOTION; MALE; MOTOR ACTIVITY; MOTOR COORDINATION; MOUSE; NEUROPHARMACOLOGY; NONHUMAN; PHARMACODYNAMICS; SLEEP TIME; ANIMAL; DRUG EFFECT; DRUG INTERACTION; SLEEP;

ANIMALS; ANTICONVULSANTS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DRUG INTERACTIONS; ETHANOL; MALE; MICE; MOTOR ACTIVITY; PROPYLENE GLYCOLS; SLEEP;

EID: 17144386594     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Fadda F., Mosca E., Colombo G., Gessa G.L.: Physiol. Behav. 47, 727 (1990).
2. Fernandez M.C., Walter F.G., Petersen L.R., Walkotte S.M.: J. Toxicol. Clin. Toxicol. 34, 437 (1996).
3. Serra M., Cuccu R., Ghiani C.A., Pisu M.G., Murgia A., Biggio G.: Neurochem. Res. 22, 693 (1997).
4. Gerasimov M.R., Ashby C.R. Gardner E.L.: Synapse 34, 11 (1999).
5. De Sarro G., Ongini E., Bertorelli R., Aguglia U., De Sarro A.: Eur. J. Pharmacol. 262, 11 (1994).
6. Devaud L.L., Fritschy J.M., Marrow A.L.: Brain Res. 796, 222 (1998).
7. Kleckner N.W., Glazewski J.C., Chen C.C., Moscrip T.D.: J. Pharmacol. Exp. Ther. 289, 886 (1999).
8. Harty T.P., Rogawski M.A.: Epilepsy Res. 39, 47 (2000).
9. Crews F.T., Morrow A.L., Criswell H., Breese G.R.: Int. Rev. Neurobiol. 39, 367 (1996).
10. Hundt W., Danysz W., Holter S.M., Spanagel R.: Psychopharmacology 135, 44 (1998).
11. Spanagel R.: Pharmacol. Biochem. Behav. 54, 645 (1996).
12. Vanover K.E.: Eur. J. Pharmacol. 368, 137 (1999).
13. Pohorecky L.A., Newman b., Sun J.: Biobehav. Rev. 41, 231 (1997).
14. Glue P., Sulowicz W., Colucci R., Banfield C., Pai S., Lin C., Affrime M.B.: Br. J. Clin. Pharmacol. 44, 91 (1997).
15. Richens A., Banfield C.R., Salfi M., Nomeri A., Lin C.C., Jensen P., Affrime M.B.: Br. J. Clin. Pharmacol. 44, 129 (1997).
16. Glue P., Banfield C.R., Perhach J.L., Mather G.G., Racha J.K., Levy R.H.: Clin. Pharmacokinet. 33, 214 (1997).
17. Weathermon R., Crabb D.W.: Alcohol. Res. Health. 23, 40 (1999).
18. Fischer W., Kittner H.: J. Neural. Transm. 105, 1129 (1998).
19. Adusumalli V.E., Yang J.T. Wong K.K., Kucharczyk N., Sofia R.D.: Drug Metab. Dispos. 19, 1116 (1991).
20. Bertorelli R., Ferri N., Adami M., Ongini E.: Pharmacol. Biochem. Behav. 53, 559 (1996).
21. Frey H.H., Bartels I.: Epilepsy Res. 27, 151 (1997).
22. Haugvicova R., Kubova H., Mares P.: Brain Dev. 20, 222 (1998).
23. Hunter J.C., Gogas K.R., Hedley L.R., Jacobson L.O., Kossotakis L., Thomson J., Fontana D.: Eur. J. Pharmacol. 324, 153 (1997).
24. Mc Gee J.H., Erikson D.J., Galbreath C.: Toxicol. Sci. 45, 225 (1998).
25. Pullen L.: in New Antiepileptic Drugs For Children. Chicago, (2000).
26. Sharp S., Bradley V.: in Felbamate efficacy in the treatment of hypersomnia, University of North Carolina (2000).
27. Pakszysz M., Rusel G., Kuszczak B.: Neurochir. Pol. Suppl. 1, 195 (2000).
28. Swinyard E.A., Woodhead J.H., Franklin M.R., Sofia R.D., Kupferberg H.J.: Epilepsia 28, 295 (1987).
29. Swinyard E.A., Sofia R.D., Kupferberg H.J.: Epilepsia 27, 27 (1986).
30. Kaufmann D.W., Pellock J.M.: Epilepsia 38, 1265 (1997).